Sign In
Affymetrix, Incorporated (AFFX)
SHARE
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Kevin M. King, President/Director/CEO
3420 Central Expressway
Santa Clara, CA 95051
US
Map it 
Phone: (408) 731-5000
Fax: (408) 731-5441
Latest news from Portfolio
-
Genetically Tailored MedicineDec 31 2008
-
Gene-Sequencing WarriorFeb 13 2008
-
Welcome to the FutureOct 15 2007
Overview
The Company is engaged in the development, manufacture, sale & service of consumables & systems for genetic analysis in the life sciences & clinical healthcare markets and create tools that advances the understanding of the molecular basis of life.
Portfolio Articles
-
Genetically Tailored Medicine
Technology, science, medicine, and business are converging to deliver more information than ever about you and your body. Bespoke medical care is coming.Dec 31 2008 -
Gene-Sequencing Warrior
Illumina C.E.O. Jay Flatley is moving fast to outmaneuver rivals in a futuristic industry that stands to make billions of dollars off your DNA.Feb 13 2008 -
Welcome to the Future
With a little help from Google, secretive Silicon Calley startup 23andMe is betting you’ll want to web-surf your own DNA. But is the science ready?
Oct 15 2007
Portfolio Blogs
-
When's a Gene Test Not a Gene Test?
Jun 25 2008
Press Releases
-
Affymetrix to Host Conference Call on July 22, 2009 to Announce Second Quarter 2009 Results Jul-08-2009, 09:00AM EDT
-
Key Milestones to Improve Operating Leverage Achieved Ahead of Schedule Jun-02-2009, 01:30PM EDT
-
Entrepreneur Magazine Picks Affymetrix as One of Top 100 Companies to Watch May-28-2009, 09:15AM EDT
-
Affymetrix to Webcast Investor Day 2009 May-20-2009, 09:00AM EDT
-
Affymetrix Appoints Gary Guthart to Board of Directors May-11-2009, 09:00AM EDT
News From Around the Web
News
-
Jul 08 2009
Employees
Number of Employees: 1,141
Revenue per Employee: $326,167
Financials
Quarterly
Annual
| Income Statement | 01/2009 | 10/2008 | 07/2008 | 04/2008 |
|---|---|---|---|---|
| Sales | 43.32 Mil. | 38.14 Mil. | 39 Mil. | 31.66 Mil. |
| Gross Operating Profit | 35.26 Mil. | 37.05 Mil. | 47.91 Mil. | 137.92 Mil. |
| Operating Income before D & A (EBITDA) | -24.51 Mil. | -12.1 Mil. | -1.32 Mil. | 94.42 Mil. |
| Total Income Before Interest Expenses (EBIT) | -274.43 Mil. | -30.1 Mil. | 68 K. | 86.58 Mil. |
| Total Net Income | -318.72 Mil. | -31.82 Mil. | -3.64 Mil. | 46.25 Mil. |
| Basic EPS, Total | -4.65 | -0.46 | -0.05 | 0.68 |
| Diluted EPS, Total | -4.65 | -0.46 | -0.05 | 0.58 |
| BALANCE STATEMENT | 01/2009 | 10/2008 | 07/2008 | 04/2008 |
|---|---|---|---|---|
| Cash and Equivalents | 113.29 Mil. | 315.15 Mil. | 325.73 Mil. | NA |
| Total Assets | 499.52 Mil. | 712.8 Mil. | 746.59 Mil. | NA |
| Total Liabilities | 78.76 Mil. | 72.57 Mil. | 78.66 Mil. | NA |
| Total Capitalization | 620 Mil. | 1.07 Bil. | 1.11 Bil. | NA |
| Cash Flow | 01/2009 | 10/2008 | 07/2008 | 04/2008 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | NA | NA |
| Net Cash From Investing Activities | NA | NA | NA | NA |
| Net Cash From Financing Activities | NA | NA | NA | NA |
| Net Change in Cash & Cash Equivalents | NA | NA | NA | NA |
| Income Statement | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|
| Sales | 152.14 Mil. | 138.72 Mil. | 97.18 Mil. | 73.63 Mil. |
| Gross Operating Profit | 258.11 Mil. | 232.6 Mil. | 258.14 Mil. | 293.97 Mil. |
| Operating Income before D & A (EBITDA) | 46.47 Mil. | 21.38 Mil. | 26.72 Mil. | 93.51 Mil. |
| Total Income Before Interest Expenses (EBIT) | 11.19 Mil. | 21.5 Mil. | -4.47 Mil. | 64.15 Mil. |
| Total Net Income | -307.92 Mil. | 12.59 Mil. | -13.7 Mil. | 57.52 Mil. |
| Basic EPS, Total | -4.49 | 0.18 | -0.2 | 0.9 |
| Diluted EPS, Total | -4.49 | 0.17 | -0.2 | 0.84 |
| BALANCE STATEMENT | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|
| Cash and Equivalents | 113.29 Mil. | 288.64 Mil. | 119.06 Mil. | 100.24 Mil. |
| Total Assets | 499.52 Mil. | 667.11 Mil. | 383.89 Mil. | 452.76 Mil. |
| Total Liabilities | 78.76 Mil. | 84.04 Mil. | 93.59 Mil. | 107.2 Mil. |
| Total Capitalization | 620 Mil. | 1.03 Bil. | 672.96 Mil. | 639.84 Mil. |
| Cash Flow | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | 31.26 Mil. | 64.61 Mil. |
| Net Cash From Investing Activities | NA | NA | -22.35 Mil. | -82.3 Mil. |
| Net Cash From Financing Activities | NA | NA | 9.76 Mil. | 74.85 Mil. |
| Net Change in Cash & Cash Equivalents | NA | NA | 18.83 Mil. | 57.64 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
1.29 Bil.
1.64 Bil.
1.21 Bil.
1.71 Bil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- To request a change please click here
Also in Portfolio.com
Most Read
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.
RSS Most Read